Background: Colorectal cancer (CRC) is the most common malignant tumor of the gastrointestinal tract with unfavorable prognosis. Therefore, novel biomarkers that may be used for new diagnostic strategies and drug-targeting therapy should be developed.
Objectives: To investigate the expression of miR-29b in CRC and its association with ETV4 and cyclin D1 expression.